Mach7 Technologies Limited (ASX:M7T)
Australia
· Delayed Price · Currency is AUD | Market Cap | 62.28M |
| Revenue (ttm) | 29.70M |
| Net Income (ttm) | -10.08M |
| Shares Out | 235.01M |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 191,623 |
| Average Volume | 140,984 |
| Open | 0.275 |
| Previous Close | 0.265 |
| Day's Range | 0.260 - 0.280 |
| 52-Week Range | 0.245 - 0.685 |
| Beta | 1.02 |
| RSI | 35.69 |
| Earnings Date | Apr 24, 2026 |
About Mach7 Technologies
Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients’ medical images; vendor-neutral archive (VNA), a vendor-agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images ... [Read more]
Financial Performance
In fiscal year 2025, Mach7 Technologies's revenue was 33.79 million, an increase of 16.00% compared to the previous year's 29.13 million. Losses were -6.20 million, -22.19% less than in 2024.
Financial StatementsNews
Mach7 Technologies Earnings Call Transcript: Q3 2026
Q3 saw improved financial discipline, with ARR up 2% and positive cash flow. FY26 revenue is expected to dip 15% due to delayed capital deals, but recurring revenue and pipeline growth remain strong. Strategic reset, cost control, and AI-driven innovation are driving future growth.
Mach7 Technologies Earnings Call Transcript: H1 2026
Completed a comprehensive reset, resulting in lower revenue but strong recurring income and gross margins. Strategic investments in modular Flamingo solutions and operational discipline position the company for growth in FY27, with a robust balance sheet and expanding market opportunities.
Q2 2026 Mach7 Technologies Ltd Activities Report Presentation Transcript
Q2 2026 Mach7 Technologies Ltd Activities Report Presentation Transcript
Mach7 Technologies Earnings Call Transcript: Q2 2026
Q2 FY26 saw stable ARR, improved cash flow, and disciplined cost management, with new product launches and strategic focus on Asia and the Middle East. Flamingo is expected to drive growth in H2 FY26 and FY27, though full impact will take time to materialize.
Mach7 Technologies Transcript: AGM 2025
The meeting reviewed strong FY 2025 financials, a successful CEO transition, and a major strategic reset focused on AI-driven imaging, operational efficiency, and global expansion. All resolutions were presented with no questions raised, and the company is positioned for growth in FY 2027 and beyond.
Mach7 Technologies Launches New Flight Path for Medical Imaging - "from Archive to Architecture" at RSNA 2025
Mach7 soars at RSNA 2025 with an entirely new image built for speed, balance, and freedom. SOUTH BURLINGTON, Vt.
Mach7 Technologies Earnings Call Transcript: Q1 2026
First quarter marked by a strategic reset, new leadership, and operational restructuring. Recurring revenue and sales orders grew, while staff costs and total payments declined. Focus remains on disciplined execution, innovation, and customer-centric transformation.
Mach7 Technologies Earnings Call Transcript: H2 2025
Revenue grew 16% year-over-year with recurring revenue now 75% of total, driving improved profitability and a strong cash position. A new customer engagement model has led to higher satisfaction, and a strategic review is underway to refine focus and guidance.
Mach7 Technologies Earnings Call Transcript: Q4 2025
Q4 FY25 saw strong cash flow, $30.2M CAR, and $23.5M ARR, with a customer-centric strategy overhaul and leadership changes. Focus is on profitable growth, improved customer engagement, and targeted R&D, with optimism for key contract renewals and the VA program going live.
Mach7 Technologies Earnings Call Transcript: Q3 2025
Q3 saw stable recurring revenue, strong cash receipts up 28% year-over-year, and continued operating cash flow positivity. Guidance for 15%-25% CAR and revenue growth is reaffirmed, with a robust sales pipeline and cost savings initiatives supporting outlook.
Mach7 Technologies Earnings Call Transcript: H1 2025
First-half revenue grew 33% year-over-year to $17.7M, with recurring revenue now covering 80% of OpEx. Strategic investments in cloud, support, and interoperability are complete, and guidance for 15%-25% revenue growth is reaffirmed for FY2025.
Mach7 Technologies Earnings Call Transcript: Q2 2025
Q2 saw strong growth in recurring revenue and cash flow, with CAR up 15.6% and ARR up 14% from Q1. Guidance for 15%-25% growth in CAR and revenue is reaffirmed, supported by a robust pipeline and a $5M share buyback. Cash position remains strong with no debt.
Mach7 Technologies Transcript: AGM 2024
The meeting highlighted record sales orders, strong recurring revenue growth, and a successful transition to a subscription model. Strategic focus remains on innovation, customer retention, and disciplined cost management, with board renewal and governance enhancements also emphasized.
Mach7 Technologies Earnings Call Transcript: Q1 2025
Q1 FY25 saw steady growth in recurring revenue, with CARR up 2% and ARR up 3.5% year-over-year. Despite a lumpy sales cycle and lower Q1 sales orders, guidance for 15%-25% revenue growth is reaffirmed, supported by a strong pipeline and strategic investments.
Mach7 Technologies Earnings Call Transcript: H2 2024
FY 2024 saw record sales orders, strong recurring revenue growth, and positive cash flow as the business transitioned to a subscription model. FY 2025 will focus on CARR growth, new customer acquisition, and a strategic investment in innovation, with profitability expected by FY 2027.
Mach7 Technologies Earnings Call Transcript: Q4 2024
Q4 saw strong growth in sales orders, recurring revenue, and cash flow, with a 52% year-over-year increase in sales orders and positive operating cash flow for FY24. The business is shifting further toward subscription revenue and maintains a robust sales pipeline for FY25.